Novel hepatitis C drugs in current trials.

@article{Kronenberger2008NovelHC,
  title={Novel hepatitis C drugs in current trials.},
  author={Bernd Kronenberger and Christoph Welsch and Nicole Forestier and Stefan Zeuzem},
  journal={Clinics in liver disease},
  year={2008},
  volume={12 3},
  pages={
          529-55, viii
        }
}
Almost half of the patients who have chronic hepatitis C cannot be cured with the current standard treatment. Recent progress in structure determination of HCV proteins and development of a subgenomic replicon system and a cell culture infectious HCV clone enabled the development of a specifically targeted antiviral therapy for hepatitis C (STAT-C). Many HCV-specific compounds are under investigation in preclinical and clinical trials. The development of agents in different classes may allow… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.

  • Canadian journal of gastroenterology = Journal canadien de gastroenterologie
  • 2010
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 70 REFERENCES

Antiviral activity of telaprevir (VX- 950) and peginterferon alfa-2a in patients with hepatitis

N Forestier, HW Reesink, CJ Weegink
  • C. Hepatology
  • 2007
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Antiviral activity of telaprevir ( VX - 950 ) and peginterferon alfa - 2 a in patients with hepatitis C

N Forestier, HW Reesink, CJ Weegink
  • 2007